Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 214

1.

HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reports.

Arfi A, Hequet D, Bataillon G, Tran-Perennou C, Farkhondeh F, Sastre-Garau X, Fourchotte V, Rouzier R, Laas E, Pouget N, Vincent-Salomon A, Jeannot E.

BMC Cancer. 2019 Apr 23;19(1):375. doi: 10.1186/s12885-019-5582-8.

2.

HPV insertional pattern as a personalized tumor marker for the optimized tumor diagnosis and follow-up of patients with HPV-associated carcinomas: a case report.

Harlé A, Guillet J, Thomas J, Demange J, Dolivet G, Peiffert D, Leroux A, Sastre-Garau X.

BMC Cancer. 2019 Mar 28;19(1):277. doi: 10.1186/s12885-019-5447-1.

3.

Genome-wide profiling of human papillomavirus DNA integration in liquid-based cytology specimens from a Gabonese female population using HPV capture technology.

Nkili-Meyong AA, Moussavou-Boundzanga P, Labouba I, Koumakpayi IH, Jeannot E, Descorps-Declère S, Sastre-Garau X, Leroy EM, Belembaogo E, Berthet N.

Sci Rep. 2019 Feb 6;9(1):1504. doi: 10.1038/s41598-018-37871-2.

4.

Nuclear factor I X is a recurrent target for HPV16 insertions in anal carcinomas.

Jeannot E, Harlé A, Holmes A, Sastre-Garau X.

Genes Chromosomes Cancer. 2018 Dec;57(12):638-644. doi: 10.1002/gcc.22675. Epub 2018 Sep 27.

PMID:
30264502
5.

Evaluation and validation of HPV real-time PCR assay for the detection of HPV DNA in oral cytobrush and FFPE samples.

Harlé A, Guillet J, Thomas J, Sastre-Garau X, Rouyer M, Ramacci C, Gilson P, Dubois C, Dolivet G, Leroux A, Salleron J, Merlin JL.

Sci Rep. 2018 Jul 27;8(1):11313. doi: 10.1038/s41598-018-29790-z.

6.

Circulating human papillomavirus DNA detected using droplet digital PCR in the serum of patients diagnosed with early stage human papillomavirus-associated invasive carcinoma.

Jeannot E, Becette V, Campitelli M, Calméjane MA, Lappartient E, Ruff E, Saada S, Holmes A, Bellet D, Sastre-Garau X.

J Pathol Clin Res. 2016 Jun 28;2(4):201-209. eCollection 2016 Oct.

7.

Ligand-receptor dissociated expression explains high TSLP without prognostic impact in human primary head and neck squamous cell carcinoma.

Guillot-Delost M, Guilleré L, Berger F, Ventre A, Michea P, Sirven P, Pattarini L, Scholer-Dahirel A, Kebir FZ, Huerre M, Chouchane-Mlik O, Lappartient E, Rodriguez J, Jouffroy T, Klijanienko J, Nicolas A, Sastre-Garau X, Honorio S, Mosseri V, Le Peltier N, Sablin MP, Le Tourneau C, Tartour É, Badoual C, Soumelis V.

Oncoimmunology. 2016 Jun 7;5(7):e1179414. doi: 10.1080/2162402X.2016.1179414. eCollection 2016 Jul.

8.

Effective antitumor therapy based on a novel antibody-drug conjugate targeting the Tn carbohydrate antigen.

Sedlik C, Heitzmann A, Viel S, Ait Sarkouh R, Batisse C, Schmidt F, De La Rochere P, Amzallag N, Osinaga E, Oppezzo P, Pritsch O, Sastre-Garau X, Hubert P, Amigorena S, Piaggio E.

Oncoimmunology. 2016 Apr 22;5(7):e1171434. doi: 10.1080/2162402X.2016.1171434. eCollection 2016 Jul.

9.

Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.

Bonsang-Kitzis H, Chaltier L, Belin L, Savignoni A, Rouzier R, Hamy AS, Sablin MP, Lerebours F, Bidard FC, Cottu P, Sastre-Garau X, Laé M, Pierga JY, Reyal F.

PLoS One. 2016 Jul 7;11(7):e0159123. doi: 10.1371/journal.pone.0159123. eCollection 2016.

10.

Identification of new candidate therapeutic target genes in head and neck squamous cell carcinomas.

Sablin MP, Dubot C, Klijanienko J, Vacher S, Ouafi L, Chemlali W, Caly M, Sastre-Garau X, Lappartient E, Mariani O, Rodriguez J, Jouffroy T, Girod A, Calugaru V, Hoffmann C, Lidereau R, Berger F, Kamal M, Bieche I, Le Tourneau C.

Oncotarget. 2016 Jul 26;7(30):47418-47430. doi: 10.18632/oncotarget.10163.

11.

Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection.

Cacheux W, Rouleau E, Briaux A, Tsantoulis P, Mariani P, Richard-Molard M, Buecher B, Dangles-Marie V, Richon S, Lazartigues J, Jeannot E, Farkhondeh F, Sastre-Garau X, de La Rochefordière A, Labib A, Falcou MC, Stevens D, Roth A, Roman-Roman S, Mitry E, Bièche I, Lièvre A.

Br J Cancer. 2016 Jun 14;114(12):1387-94. doi: 10.1038/bjc.2016.144. Epub 2016 May 24.

12.

Protein Tyrosine Phosphatase 4A3 (PTP4A3) Promotes Human Uveal Melanoma Aggressiveness Through Membrane Accumulation of Matrix Metalloproteinase 14 (MMP14).

Maacha S, Anezo O, Foy M, Liot G, Mery L, Laurent C, Sastre-Garau X, Piperno-Neumann S, Cassoux N, Planque N, Saule S.

Invest Ophthalmol Vis Sci. 2016 Apr 1;57(4):1982-90. doi: 10.1167/iovs.15-18780.

PMID:
27096756
13.

COFAC-Col: A Cervical Cancer Control Networking Initiative in Five French-Speaking African Countries.

Berthet N, Berling C, Nabi H, Woto Gaye G, Toure Kane C, Diop-Ndiaye H, Koumakpayi IH, Engohan Aloghe C, Bisvigou U, Didi Coulibaly J, Faye Kette H, Koffi E, Ekra D, Moussavou Boundzanga P, Labouba I, NJouom R, Tebeu PM, Sandjong I, Atangana PA, N'Kegoum B, Rakoto-Andrianarivelo M, Rakotomalala FA, Randrianjafisamindrakotroka N, Andriamampionona TF, Ratovohery A, Sastre-Garau X, Diop M.

Cancer Epidemiol Biomarkers Prev. 2016 Jun;25(6):1004-5. doi: 10.1158/1055-9965.EPI-15-1248. Epub 2016 Mar 23. No abstract available.

14.

Mechanistic signatures of HPV insertions in cervical carcinomas.

Holmes A, Lameiras S, Jeannot E, Marie Y, Castera L, Sastre-Garau X, Nicolas A.

NPJ Genom Med. 2016 Mar 16;1:16004. doi: 10.1038/npjgenmed.2016.4. eCollection 2016.

15.

LIN7A is a major determinant of cell-polarity defects in breast carcinomas.

Gruel N, Fuhrmann L, Lodillinsky C, Benhamo V, Mariani O, Cédenot A, Arnould L, Macgrogan G, Sastre-Garau X, Chavrier P, Delattre O, Vincent-Salomon A.

Breast Cancer Res. 2016 Feb 17;18(1):23. doi: 10.1186/s13058-016-0680-x.

16.

Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay.

Mouttet D, Laé M, Caly M, Gentien D, Carpentier S, Peyro-Saint-Paul H, Vincent-Salomon A, Rouzier R, Sigal-Zafrani B, Sastre-Garau X, Reyal F.

PLoS One. 2016 Feb 1;11(2):e0146474. doi: 10.1371/journal.pone.0146474. eCollection 2016.

17.

Merkel cell carcinoma: value of sentinel lymph-node status and adjuvant radiation therapy.

Servy A, Maubec E, Sugier PE, Grange F, Mansard S, Lesimple T, Marinho E, Couturaud B, Girod A, Albert S, Dendale R, Calitchi E, Sarda L, Chanal J, Deschamps L, Sastre-Garau X, Laroche L, Crickx B, Avril MF.

Ann Oncol. 2016 May;27(5):914-9. doi: 10.1093/annonc/mdw035. Epub 2016 Jan 24.

PMID:
26811346
18.

Ovarian Cancers Harboring Inactivating Mutations in CDK12 Display a Distinct Genomic Instability Pattern Characterized by Large Tandem Duplications.

Popova T, Manié E, Boeva V, Battistella A, Goundiam O, Smith NK, Mueller CR, Raynal V, Mariani O, Sastre-Garau X, Stern MH.

Cancer Res. 2016 Apr 1;76(7):1882-91. doi: 10.1158/0008-5472.CAN-15-2128. Epub 2016 Jan 19.

19.

Follicle-Stimulating Hormone Receptor Expression in Endometriotic Lesions and the Associated Vasculature: An Immunohistochemical Study.

Robin B, Planeix F, Sastre-Garau X, Pichon C, Olesen TK, Gogusev J, Ghinea N.

Reprod Sci. 2016 Jul;23(7):885-91. doi: 10.1177/1933719115623647. Epub 2015 Dec 23.

PMID:
26704526
20.

Diagnostic Accuracy of Intraocular Tumor Size Measured with MR Imaging in the Prediction of Postlaminar Optic Nerve Invasion and Massive Choroidal Invasion of Retinoblastoma.

De Jong MC, van der Meer FJ, Göricke SL, Brisse HJ, Galluzzi P, Maeder P, Sirin S, De Francesco S, Sastre-Garau X, Metz KA, Cerase A, Noij DP, van der Valk P, Moll AC, Castelijns JA, de Graaf P; European Retinoblastoma Imaging Collaboration.

Radiology. 2016 Jun;279(3):817-26. doi: 10.1148/radiol.2015151213. Epub 2015 Dec 19.

PMID:
26690907
21.

Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.

Bonsang-Kitzis H, Chaltier L, Belin L, Savignoni A, Rouzier R, Sablin MP, Lerebours F, Bidard FC, Cottu P, Sastre-Garau X, Laé M, Pierga JY, Reyal F.

PLoS One. 2015 Dec 18;10(12):e0144359. doi: 10.1371/journal.pone.0144359. eCollection 2015. Erratum in: PLoS One. 2016;11(7):e0159123.

22.

Human papillomavirus (HPV) insertional mutation as a dynamic & specific tumour biomarker in HPV-associated carcinoma.

Sastre-Garau X.

Indian J Med Res. 2015 Nov;142(5):507-8. doi: 10.4103/0971-5916.171266. No abstract available.

23.

MAP3K8/TPL-2/COT is a potential predictive marker for MEK inhibitor treatment in high-grade serous ovarian carcinomas.

Gruosso T, Garnier C, Abelanet S, Kieffer Y, Lemesre V, Bellanger D, Bieche I, Marangoni E, Sastre-Garau X, Mieulet V, Mechta-Grigoriou F.

Nat Commun. 2015 Oct 12;6:8583. doi: 10.1038/ncomms9583.

24.

Characterization of the Microenvironment in Positive and Negative Sentinel Lymph Nodes from Melanoma Patients.

Messaoudene M, Périer A, Fregni G, Neves E, Zitvogel L, Cremer I, Chanal J, Sastre-Garau X, Deschamps L, Marinho E, Larousserie F, Maubec E, Avril MF, Caignard A.

PLoS One. 2015 Jul 28;10(7):e0133363. doi: 10.1371/journal.pone.0133363. eCollection 2015.

25.

Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification.

Ng CK, Martelotto LG, Gauthier A, Wen HC, Piscuoglio S, Lim RS, Cowell CF, Wilkerson PM, Wai P, Rodrigues DN, Arnould L, Geyer FC, Bromberg SE, Lacroix-Triki M, Penault-Llorca F, Giard S, Sastre-Garau X, Natrajan R, Norton L, Cottu PH, Weigelt B, Vincent-Salomon A, Reis-Filho JS.

Genome Biol. 2015 May 22;16:107. doi: 10.1186/s13059-015-0657-6.

26.

Breast Cancer Cell-Derived GM-CSF Licenses Regulatory Th2 Induction by Plasmacytoid Predendritic Cells in Aggressive Disease Subtypes.

Ghirelli C, Reyal F, Jeanmougin M, Zollinger R, Sirven P, Michea P, Caux C, Bendriss-Vermare N, Donnadieu MH, Caly M, Fourchotte V, Vincent-Salomon A, Sigal-Zafrani B, Sastre-Garau X, Soumelis V.

Cancer Res. 2015 Jul 15;75(14):2775-87. doi: 10.1158/0008-5472.CAN-14-2386. Epub 2015 May 14.

27.

Histo-genomic stratification reveals the frequent amplification/overexpression of CCNE1 and BRD4 genes in non-BRCAness high grade ovarian carcinoma.

Goundiam O, Gestraud P, Popova T, De la Motte Rouge T, Fourchotte V, Gentien D, Hupé P, Becette V, Houdayer C, Roman-Roman S, Stern MH, Sastre-Garau X.

Int J Cancer. 2015 Oct 15;137(8):1890-900. doi: 10.1002/ijc.29568. Epub 2015 Apr 29.

28.

Endothelial follicle-stimulating hormone receptor expression in invasive breast cancer and vascular remodeling at tumor periphery.

Planeix F, Siraj MA, Bidard FC, Robin B, Pichon C, Sastre-Garau X, Antoine M, Ghinea N.

J Exp Clin Cancer Res. 2015 Feb 5;34:12. doi: 10.1186/s13046-015-0128-7.

29.

Germline RAD51B truncating mutation in a family with cutaneous melanoma.

Wadt KA, Aoude LG, Golmard L, Hansen TV, Sastre-Garau X, Hayward NK, Gerdes AM.

Fam Cancer. 2015 Jun;14(2):337-40. doi: 10.1007/s10689-015-9781-4.

PMID:
25600502
30.

The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma.

Montes de Oca R, Gurard-Levin ZA, Berger F, Rehman H, Martel E, Corpet A, de Koning L, Vassias I, Wilson LO, Meseure D, Reyal F, Savignoni A, Asselain B, Sastre-Garau X, Almouzni G.

Mol Oncol. 2015 Mar;9(3):657-74. doi: 10.1016/j.molonc.2014.11.002. Epub 2014 Nov 20.

31.

Value of combined cytology and molecular information in the diagnosis of soft tissue tumors.

Klijanienko J, Pierron G, Sastre-Garau X, Theocharis S.

Cancer Cytopathol. 2015 Mar;123(3):141-51. doi: 10.1002/cncy.21496. Epub 2014 Dec 8.

32.

Assessment of early-stage optic nerve invasion in retinoblastoma using high-resolution 1.5 Tesla MRI with surface coils: a multicentre, prospective accuracy study with histopathological correlation.

Brisse HJ, de Graaf P, Galluzzi P, Cosker K, Maeder P, Göricke S, Rodjan F, de Jong MC, Savignoni A, Aerts I, Desjardins L, Moll AC, Hadjistilianou T, Toti P, van der Valk P, Castelijns JA, Sastre-Garau X; European Retinoblastoma Imaging Collaboration (ERIC).

Eur Radiol. 2015 May;25(5):1443-52. doi: 10.1007/s00330-014-3514-1. Epub 2014 Nov 30.

PMID:
25433413
33.

Polarity gene alterations in pure invasive micropapillary carcinomas of the breast.

Gruel N, Benhamo V, Bhalshankar J, Popova T, Fréneaux P, Arnould L, Mariani O, Stern MH, Raynal V, Sastre-Garau X, Rouzier R, Delattre O, Vincent-Salomon A.

Breast Cancer Res. 2014 May 8;16(3):R46. doi: 10.1186/bcr3653.

34.

Extracellular signal-regulated kinase (ERK) expression and activation in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.

Theocharis S, Kotta-Loizou I, Klijanienko J, Giaginis C, Alexandrou P, Dana E, Rodriguez J, Patsouris E, Sastre-Garau X.

Tumour Biol. 2014 Jul;35(7):6455-65. doi: 10.1007/s13277-014-1853-9. Epub 2014 Mar 30.

PMID:
24682903
35.

Targeting Bcl-2/Bcl-XL induces antitumor activity in uveal melanoma patient-derived xenografts.

Némati F, de Montrion C, Lang G, Kraus-Berthier L, Carita G, Sastre-Garau X, Berniard A, Vallerand D, Geneste O, de Plater L, Pierré A, Lockhart B, Desjardins L, Piperno-Neumann S, Depil S, Decaudin D.

PLoS One. 2014 Jan 13;9(1):e80836. doi: 10.1371/journal.pone.0080836. eCollection 2014.

36.

Extensive pure ductal carcinoma in situ of the breast: identification of predictors of associated infiltrating carcinoma and lymph node metastasis before immediate reconstructive surgery.

Guillot E, Vaysse C, Goetgeluck J, Falcou MC, Couturaud B, Fitoussi A, Fourchotte V, Laki F, Malhaire C, Sigal-Zafrani B, Sastre-Garau X, Bollet MA, Mosseri V, Reyal F.

Breast. 2014 Apr;23(2):97-103. doi: 10.1016/j.breast.2013.12.002. Epub 2013 Dec 31.

PMID:
24388733
37.

Mature cytotoxic CD56(bright)/CD16(+) natural killer cells can infiltrate lymph nodes adjacent to metastatic melanoma.

Messaoudene M, Fregni G, Fourmentraux-Neves E, Chanal J, Maubec E, Mazouz-Dorval S, Couturaud B, Girod A, Sastre-Garau X, Albert S, Guédon C, Deschamps L, Mitilian D, Cremer I, Jacquelot N, Rusakiewicz S, Zitvogel L, Avril MF, Caignard A.

Cancer Res. 2014 Jan 1;74(1):81-92. doi: 10.1158/0008-5472.CAN-13-1303. Epub 2013 Nov 13.

38.

Genomic instability: a stronger prognostic marker than proliferation for early stage luminal breast carcinomas.

Vincent-Salomon A, Benhamo V, Gravier E, Rigaill G, Gruel N, Robin S, de Rycke Y, Mariani O, Pierron G, Gentien D, Reyal F, Cottu P, Fourquet A, Rouzier R, Sastre-Garau X, Delattre O.

PLoS One. 2013 Oct 15;8(10):e76496. doi: 10.1371/journal.pone.0076496. eCollection 2013.

39.

Germline mutation in the RAD51B gene confers predisposition to breast cancer.

Golmard L, Caux-Moncoutier V, Davy G, Al Ageeli E, Poirot B, Tirapo C, Michaux D, Barbaroux C, d'Enghien CD, Nicolas A, Castéra L, Sastre-Garau X, Stern MH, Houdayer C, Stoppa-Lyonnet D.

BMC Cancer. 2013 Oct 19;13:484. doi: 10.1186/1471-2407-13-484.

40.

Ephrin receptor (Eph) -A1, -A2, -A4 and -A7 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.

Theocharis S, Klijanienko J, Giaginis C, Alexandrou P, Patsouris E, Sastre-Garau X.

Pathol Oncol Res. 2014 Apr;20(2):277-84. doi: 10.1007/s12253-013-9692-3. Epub 2013 Sep 11.

PMID:
24022400
41.

New blocking antibodies impede adhesion, migration and survival of ovarian cancer cells, highlighting MFGE8 as a potential therapeutic target of human ovarian carcinoma.

Tibaldi L, Leyman S, Nicolas A, Notebaert S, Dewulf M, Ngo TH, Zuany-Amorim C, Amzallag N, Bernard-Pierrot I, Sastre-Garau X, Théry C.

PLoS One. 2013 Aug 16;8(8):e72708. doi: 10.1371/journal.pone.0072708. eCollection 2013.

42.

Loss of heterozygosity at 13q13 and 14q32 predicts BRCA2 inactivation in luminal breast carcinomas.

Pécuchet N, Popova T, Manié E, Lucchesi C, Battistella A, Vincent-Salomon A, Caux-Moncoutier V, Bollet M, Sigal-Zafrani B, Sastre-Garau X, Stoppa-Lyonnet D, Stern MH.

Int J Cancer. 2013 Dec 15;133(12):2834-42. doi: 10.1002/ijc.28315. Epub 2013 Jul 10.

43.

Germline BAP1 mutations predispose to renal cell carcinomas.

Popova T, Hebert L, Jacquemin V, Gad S, Caux-Moncoutier V, Dubois-d'Enghien C, Richaudeau B, Renaudin X, Sellers J, Nicolas A, Sastre-Garau X, Desjardins L, Gyapay G, Raynal V, Sinilnikova OM, Andrieu N, Manié E, de Pauw A, Gesta P, Bonadona V, Maugard CM, Penet C, Avril MF, Barillot E, Cabaret O, Delattre O, Richard S, Caron O, Benfodda M, Hu HH, Soufir N, Bressac-de Paillerets B, Stoppa-Lyonnet D, Stern MH.

Am J Hum Genet. 2013 Jun 6;92(6):974-80. doi: 10.1016/j.ajhg.2013.04.012. Epub 2013 May 16.

44.

Long-term prognostic performance of Ki67 rate in early stage, pT1-pT2, pN0, invasive breast carcinoma.

Reyal F, Hajage D, Savignoni A, Feron JG, Bollet MA, Kirova Y, Fourquet A, Pierga JY, Cottu P, Dieras V, Fourchotte V, Laki F, Alran S, Asselain B, Vincent-Salomon A, Sigal-Zafrani B, Sastre-Garau X.

PLoS One. 2013;8(3):e55901. doi: 10.1371/journal.pone.0055901. Epub 2013 Mar 19.

45.

Patient-derived xenografts recapitulate molecular features of human uveal melanomas.

Laurent C, Gentien D, Piperno-Neumann S, Némati F, Nicolas A, Tesson B, Desjardins L, Mariani P, Rapinat A, Sastre-Garau X, Couturier J, Hupé P, de Koning L, Dubois T, Roman-Roman S, Stern MH, Barillot E, Harbour JW, Saule S, Decaudin D.

Mol Oncol. 2013 Jun;7(3):625-36. doi: 10.1016/j.molonc.2013.02.004. Epub 2013 Feb 26.

46.

Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleation.

Aerts I, Sastre-Garau X, Savignoni A, Lumbroso-Le Rouic L, Thebaud-Leculée E, Frappaz D, Coze C, Thomas C, Gauthier-Villars M, Lévy-Gabriel C, Brisse HJ, Desjardins L, Doz F.

J Clin Oncol. 2013 Apr 10;31(11):1458-63. doi: 10.1200/JCO.2012.42.3962. Epub 2013 Mar 4.

PMID:
23460706
47.

Prevalence and distribution of high-risk human papillomavirus genotypes in invasive carcinoma of the uterine cervix in Uruguay.

Berois N, De Cremoux P, Mazal D, Sica A, Cedeira M, Caserta B, Barrios E, Osinaga E, Sastre-Garau X.

Int J Gynecol Cancer. 2013 Mar;23(3):527-32. doi: 10.1097/IGC.0b013e318285e753.

PMID:
23392403
48.

Uterine cervix carcinoma: recent biological data and update for improving follow-up and treatment.

Javier MG, Sastre-Garau X.

Isr Med Assoc J. 2012 Nov;14(11):700-4. Review. No abstract available.

49.

Non-sentinel lymph node metastasis prediction in breast cancer with metastatic sentinel lymph node: impact of molecular subtypes classification.

Reyal F, Belichard C, Rouzier R, de Gournay E, Senechal C, Bidard FC, Pierga JY, Cottu P, Lerebours F, Kirova Y, Feron JG, Fourchotte V, Vincent-Salomon A, Guinebretiere JM, Sigal-Zafrani B, Sastre-Garau X, De Rycke Y, Coutant C.

PLoS One. 2012;7(10):e47390. doi: 10.1371/journal.pone.0047390. Epub 2012 Oct 9.

50.

Prediction of axillary lymph node status in male breast carcinoma.

Vaysse C, Sroussi J, Mallon P, Feron JG, Rivain AL, Ngo C, Belichard C, Lasry S, Pierga JY, Couturaud B, Fitoussi A, Laki F, Fourchotte V, Alran S, Kirova Y, Vincent-Salomon A, Sastre-Garau X, Sigal-Zafrani B, Rouzier R, Reyal F.

Ann Oncol. 2013 Feb;24(2):370-6. doi: 10.1093/annonc/mds283. Epub 2012 Oct 9.

PMID:
23051951

Supplemental Content

Loading ...
Support Center